kabutan
N225

65,020.94

+1.26%
TOPIX

4,103.23

+0.03%
USDJPY

156.36

+0.35%
Kabutan Concierge Closed Beta - Apply now

D.Western Therapeutics Institute, First Half Net Income Loss Narrows, Apr-Jun Net Income Loss Narrows

Thu Aug 14, 2025 3:30 pm JST Earnings

4576 D.Western Therapeutics Institute, Inc. 【J-GAAP】

Earnings Report

D.Western Therapeutics Institute, Inc. <4576> [TSE Growth] announced its financial results after the market closed on August 14th (15:30). The consolidated net loss for the cumulative second quarter of the fiscal year ending December 2025 (January to June) was a reduced loss of 316 million yen (compared to a loss of 520 million yen in the same period last year).

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net loss for the July to December period (second half) is expected to further decrease loss of 364 million yen (compared to a loss of 770 million yen in the same period last year).

In the most recent three-month period, from April to June (2Q), the consolidated net loss improved to a deficit of 166 million yen (compared to a loss of 200 million yen in the same period last year). However, the operating profit/loss margin drastically worsened from -110.1% in the same period last year to -216.9%.

Kabutan News

Actual Performance and Financial Trends

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating
Profit		 Ordinary
Profit		 Net
Profit		 Adj.
EPS		 Progress Rate
vs. First Half		 Announce Accounting
Standards
Jan - Jun, 2023 		187M -258M -254M -247M -7.9 ー Aug 10, 2023 J-GAAP
Jan - Jun, 2024 		223M -449M -459M -520M -16.2 ー Aug 9, 2024 J-GAAP
Jan - Jun, 2025 		173M -309M -316M -316M -7.1 ー Aug 14, 2025 J-GAAP
YoY -22.4% +31.2% +31.2% +39.2% +56.2%
First Half Results vs. Previous Guidance
Fiscal Year Revenue Operating
Profit		 Ordinary
Profit		 Net
Profit		 Adj.
EPS		 Adj.
Dividend		 Announce Accounting
Standards
Jan - Jun, 2025 Guidance ー ー ー ー ー 0 Feb 10, 2025 J-GAAP
Jan - Jun, 2025 Results 173M -309M -316M -316M -7.1 0 Aug 14, 2025 J-GAAP
Revision Rate ー ー ー ー ー

Current Period Guidance

Second Half Results
Fiscal Year Revenue Operating
Profit		 Ordinary
Profit		 Net
Profit		 Adj.
EPS		 Adj.
Dividend		 Announce Accounting
Standards
Jul - Dec, 2024 		248M -760M -769M -770M -21.9 0 Feb 10, 2025 J-GAAP
Guidance
Jul - Dec, 2025 		227M -361M -364M -364M -6.7 0 Aug 14, 2025 J-GAAP
YoY -8.5% +52.5% +52.7% +52.7% +69.4%
Current Period Guidance
Fiscal Year Revenue Operating
Profit		 Ordinary
Profit		 Net
Profit		 Adj.
EPS		 Adj.
Dividend		 Announce Accounting
Standards
Dec, 2023 		428M -798M -796M -812M -25.6 0 Feb 9, 2024 J-GAAP
Dec, 2024 		471M -1,209M -1,228M -1,290M -36.7 0 Feb 10, 2025 J-GAAP
Guidance
Dec, 2025 		400M -670M -680M -680M -12.5 0 Feb 10, 2025 J-GAAP
YoY -15.1% +44.6% +44.6% +47.3% +65.9%

Quarterly Results

Fiscal Year Revenue Operating
Profit		 Ordinary
Profit		 Net
Profit		 Adj.
EPS		 Operating
Profit Margin		 Announce Accounting
Standards
Apr - Jun, 2024 		119M -131M -139M -200M -6.2 -110.1% Aug 9, 2024 J-GAAP
Jul - Sep, 2024 		125M -198M -206M -207M -6.2 -158.4% Nov 14, 2024 J-GAAP
Oct - Dec, 2024 		123M -562M -563M -563M -16.0 -456.9% Feb 10, 2025 J-GAAP
Jan - Mar, 2025 		96M -142M -149M -150M -3.4 -147.9% May 15, 2025 J-GAAP
Apr - Jun, 2025 		77M -167M -167M -166M -3.7 -216.9% Aug 14, 2025 J-GAAP
YoY -35.3% -27.5% -20.1% +17.0% +40.1%

Related Articles